1643452

特拉唑嗪 盐酸盐 二水合物

United States Pharmacopeia (USP) Reference Standard

• 同義詞: Terazosin hydrochloride dihydrate, 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine hydrochloride dihydrate
• 經驗公式（希爾表示法）: C₁₉H₂₅N₅O₄ · HCl · 2H₂O
• CAS號碼: 70024-40-7
• 分子量：: 459.92
• MDL號碼: MFCD00941408
• 分類程式碼代碼: 41116107
• PubChem物質ID: 329751228
• NACRES: NA.24

屬性

• 等級: pharmaceutical primary standard
• API 家族: terazosin
• 製造商／商標名: USP
• 應用: pharmaceutical (small molecule)
• 形式: neat
• SMILES 字串: O.O.Cl.COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4
• InChI: 1S/C19H25N5O4.ClH.2H2O/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;;;/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22);1H;2*1H2
• InChI 密鑰: NZMOFYDMGFQZLS-UHFFFAOYSA-N
• 基因資訊: human ... ADRA1A(148) , ADRA1B(147) , ADRA1D(146)

描述

一般說明

Terazosin hydrochloride is a quinazoline derivative. It is a alpha-1-selective adrenoceptor blocking agent. It has been used to treat hypertension, as it helps the blood vessels to relax, expand and improves blood flow.

應用

Terazosin hydrochloride USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Terazosin Capsules
• Terazosin Tablets

分析報告

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

其他說明

Sales restrictions may apply.

安全資訊

• 象形圖: GHS07
• 訊號詞: Warning
• 危險聲明: H319
• 防範說明: P264 - P280 - P305 + P351 + P338 - P337 + P313
• 危險分類: Eye Irrit. 2
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable